The abstract is read at the publisher; the summary is JClub's.
Genotype-Restricted Likelihood estimates cumulative risks by age for heterozygous germline BAP1 (likely) pathogenic variant carriers, reaching 58.6% for breast cancer by 80 years.
- Why it matters: Ascertainment bias can distort cancer risk estimates in BAP1 tumor predisposition syndrome, limiting how well clinicians can plan surveillance for affected heterozygotes.
- What they did: The study analyzed 26 families with 90 heterozygotes and used the Genotype-Restricted Likelihood method to estimate cumulative risk and relative risk versus population incidence.
- The result: By 80 years, cumulative risk was 7.3% for uveal melanoma, 16.1% for cutaneous melanoma, 49.4% for renal cell carcinoma, 8.5% for malignant mesothelioma, 9.8% for lung cancer, and 58.6% for breast cancer.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.